NEW YORK, Jan 5 – Following its recent licensing deal with Affymetrix for low and medium density microarrays, Genomic Solutions is planning to expand its presence in this field through offering six different specialty GeneMap arrays in combination with its existing instrumentation, the company said Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.